Clinical characteristics and long-term outcome in patients with heart failure complicating acute myocardial infarction;Características clínicas y evolución a largo plazo de pacientes con insuficiencia cardíaca como complicación del infarto agudo de miocardio

Revista Espanola de Cardiologia

Volumn 58, Issue 7, 2005, Pages 789-796

  Macín, Stella Maris ^a   Perna, Eduardo Roque ^a   Augier, Natalia ^a   Cialzeta, Jorge ^a   Farías, Eduardo Francisco ^a   Fontana, Mariela ^a   Agüero, Marcelo ^a   Badaracco, Jorge Reynaldo ^a  

^a Instituto de Cardiología Juana F Cabral ^*  (Argentina)

Author keywords

Heart failure; Myocardial infarction; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE REPERFUSION; HEART SOUND; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; LEUKOCYTOSIS; LONGITUDINAL STUDY; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PERICARDITIS; PREDICTION; PROGNOSIS; Q WAVE; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

EID: 23644444337     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077230     Document Type: Article

References (35)

1. Hellermann JP, Jacobsen SJ, Gersh BJ, Rodeheffer RJ, Reeder GS, Roger VL. Heart failure after myocardial infarction: a review. Am J Med. 2002;113:324-30.
2. Vaur L, Danchin N, Genes N, Dubroca I, Etienne S, Ferrieres J, et al. Epidemiology of myocardial infarction in France: therapeutic and prognostic implications of heart failure during the acute phase. Am Heart J. 1999;137:49-58.
3. Brscic E, Bergerone S, Gagnor A. Acute ischemic heart disease. Am Heart J. 2000;139:979-84.
4. Otterstad JE, John Sutton MG, Froeland GS, Holme I, Skjaerpe T, Hall C. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline value (2-7 days) and changes at 3 months in patients with preserved systolic function. Eur Heart J. 2002;23:1011-20.
5. McClements, Weyman A, Newell J, Picard MH. Echocardiography determinants of left ventricular ejection fraction after acute myocardial infarction. Am Heart J. 2000;140:284-90.
6. Bosimini E, Giannuzzi P, Temporelli PL, Gentile F, Lucci D, Maggioni A, et al. Electrocardiography evolutionary changes and left ventricular remodeling after acute myocardial infarction: results of the GISSI-3 Echo substudy. J Am Coll Cardiol. 2000;35:127-35.
7. Wu A, Parsons L, Every N, Bates E. Hospital outcome in patients presenting with congestive heart failure complicating acute myocardial infarction. A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 2002;40:1389-94.
8. Fresco C, Carinci F, Maggioni AP, Ciampi A, Nicolucci A, Santoro E, et al. Very early assessments of risk for in-hospital death among 11.483 patients with acute myocardial infarction. Am Heart J. 1999;138:1058-64.
9. Ward SR, Larson MG, Pieper KS, Schwaiger M, Calif RM, Topol EJ. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. Am J Cardiol. 1997;79:539-44.
10. Alí A, Rybicki B, Alam M, Wulbrecht N, Richer Cornish K, Sabbah HN, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 1999;138:1133-9.
11. O'Connor CM, Hathaway WR, Bates E, Leimberger JD, Sigmon KN, Kereiakes DJ. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic theraphy for acute myocardial infarction. Development of a predictive model. Am Heart J. 1997;133:663-73.
12. Mukamal KL. Increased risk of congestive heart failure among infarctions with nighttime onset. Am Heart J. 2000;140:438-42.
13. Rott D, Behar S, Leor J, for Working Group on Intensive Cardiac Care, Israel Heart Society. Effect on survival of acute myocardial infarction in Killip classification in patients undergoing invasive coronary procedure. Am J Cardiol. 2001;87:618-23.
14. Werns AW, Bates ER. Enduring value of Killip classification. Am Heart J. 1999;137:213-5.
15. Miller WL, Wright RS, Grill JP, Kopecky SL. Improved survival after acute myocardial infarction in patients with advanced Killip class. Clin Cardiol. 2000;23:751-8.
16. Rohlfs I, Elosúa R, Masiá R, Sala J, Marrugat J. REGICOR. Tendencias en la proporción de pacientes menores de 75 años con infarto agudo de miocardio que presentan Killip III-IV. Variables asociadas con su aparición y con el pronóstico: 1978-1997. Rev Esp Cardiol. 2002;55:1117-23.
17. Cohen MG, Granger CB, Ohman EM, Stebbins AL, Grinfeld LR, Cagide AM, et al. Outcome of hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol. 1999;34:1729-37.
18. Yarzebski J, Bujor CF, Lessart D, Gore JM, Golberg RJ. Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: a population-based persepective. Am Heart J. 2004;147:690-7.
19. Giuliano RP, Llevadot J, Wilcox RG. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST elevation myocardial infarction treated with fibrinolysis. Results from inTIME-II. Eur Heart J. 2001;22:1702-15.
20. Hasdai D, Topol E, Kilaru R, Battler A, Harrington RA, Vahanian A, et al. Frecuency, patient characteristics, and outcome of mild-to-moderate heart failure complication ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials. Am Heart J. 2003; 145:73-9.
21. Poulsen S, Jensen S, Egstrup, K. Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction. Am Heart J. 1999;137:910-8.
22. Flather M, Yusuf S, Kober L, Pfeffer M, Hall M, Murray G, et al. ACE-inhibitors have significant benefits for people with heart failure and left ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 2000;355;1575-81.
23. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2004;110:e82-292.
24. Aronow W. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Society. 1996;44:1-4.
25. Howard P. Optimizing beta-blocker use after myocardial infarction. Am Family Physician. 2000;62:1-7.
26. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet. 2001; 357:1385-90.
27. Emanuelsson H, Karlson BW, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J. 1994;15:761-86.
28. Aronow W. Heart failure complicating acute myocardial infarction. Clin Geriatr Med. 2000;16:535-48.
29. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R. ISIS 2: 10 year survival among patients with suspected acute myocardial infarction in randomized comparison of intraven streptokinase, oral aspirin, both, or neither. The ISIS-2 Collaborative Group. BMJ. 1998;316:1337-43.
30. Kashani A, Guiliano RP, Antaman EM, Marrow DA, Gibson CM, Murphy S. Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction. Eur Heart J. 2004;25;1702-10.
31. White HD, Barbash GI, Califf RM, Simes JR, Granger CB, Weabver D, et al, for the GUSTO I Investigators. Age and outcome with contemporary thrombolytic theraphy: results from the GUSTO-I Trial. Circulation. 1996;94:1826-33.
32. Pabón Osuna P, Arós Borau F, San José Garagarza JM, Bermejo García J, Lopez Bescós L, Montón Rodríguez AJ. Trombólisis en el anciano con infarto agudo de miocardio. El estudio PRIAMHO. Rev Esp Cardiol. 2000;53:1443-52.
33. Bertolasi C, Mauro V. Infarto de miocardio en el anciano. Rev Esp Cardiol. 2000;53:1428-31.
34. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.
35. Wong CHK, French JK, Gao, W, White H. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of thrombolysis in myocardial infarction 3 flow after streptokinase. Am Heart J. 2003;145:95-102.